An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer
Conditions: Prostate Cancer; Metastatic Castration-Resistant Prostate Cancer (mCRPC) Interventions: Drug: AZD4635; Drug: Oleclumab; Drug: Durvalumab Sponsor: AstraZeneca Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials